Related references
Note: Only part of the references are listed.ddpcRquant: threshold determination for single channel droplet digital PCR experiments
Wim Trypsteen et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg et al.
BLOOD (2014)
Analysis of BRCA2 loss of heterozygosity in tumor tissue using droplet digital polymerase chain reaction
Rory L. Cochran et al.
HUMAN PATHOLOGY (2014)
Detection and Quantification of BCR-ABL1 Fusion Transcripts by Droplet Digital PCR
Lawrence J. Jennings et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Killer-cell Immunoglobulin-like Receptor gene linkage and copy number variation analysis by droplet digital PCR
Chrissy h Roberts et al.
GENOME MEDICINE (2014)
Molecular cytogenetics: recent developments and applications in cancer
K. Das et al.
CLINICAL GENETICS (2013)
Characterization of translocations in mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver
James Mathews et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Comparison of Droplet Digital PCR to Real-Time PCR for Quantitative Detection of Cytomegalovirus
R. T. Hayden et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Absolute quantification by droplet digital PCR versus analog real-time PCR
Christopher M. Hindson et al.
NATURE METHODS (2013)
Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples
Nicholas J. Heredia et al.
METHODS (2013)
Single molecule quantitation and sequencing of rare translocations using microfluidic nested digital PCR
Joe Shuga et al.
NUCLEIC ACIDS RESEARCH (2013)
Highly Precise Measurement of HIV DNA by Droplet Digital PCR
Matthew C. Strain et al.
PLOS ONE (2013)
Evaluation of a Droplet Digital Polymerase Chain Reaction Format for DNA Copy Number Quantification
Leonardo B. Pinheiro et al.
ANALYTICAL CHEMISTRY (2012)
Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation
Alexandra S. Whale et al.
NUCLEIC ACIDS RESEARCH (2012)
Detecting biomarkers with microdroplet technology
Valerie Taly et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
Whole Cancer Genome Sequencing by Next-Generation Methods
Jeffrey S. Ross et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
Chronic Myeloid Leukemia: Current Perspectives
Yanming Zhang et al.
CLINICS IN LABORATORY MEDICINE (2011)
Quantitative and sensitive detection of rare mutations using droplet-based microfluidics
Deniz Pekin et al.
LAB ON A CHIP (2011)
PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors
Filip Janku et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure
V. Grossmann et al.
LEUKEMIA (2011)
Rapid KRAS, EGFR, BRAF and PIK3CA Mutation Analysis of Fine Needle Aspirates from Non-Small-Cell Lung Cancer Using Allele-Specific qPCR
Ronald van Eijk et al.
PLOS ONE (2011)
Minimal Residual Disease and Discontinuation of Therapy in Chronic Myeloid Leukemia: Can We Aim at a Cure?
Junia V. Melo et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Incorporation of measurement of DNA integrity into qPCR assays
Michael J. Brisco et al.
BIOTECHNIQUES (2010)
Quantifying EGFR Alterations in the Lung Cancer Genome with Nanofluidic Digital PCR Arrays
Jun Wang et al.
CLINICAL CHEMISTRY (2010)
Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation
J. Score et al.
LEUKEMIA (2010)
BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia
B. A. Burke et al.
LEUKEMIA (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines
Anna Virgili et al.
MOLECULAR CYTOGENETICS (2010)
Single molecule detection in nanofluidic digital array enables accurate measurement of DNA copy number
Somanath Bhat et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2009)
Genomic translocation breakpoint sequences are conserved in BCR-ABL1 cell lines despite the presence of amplification
David M. Ross et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
Tony K. F. Yung et al.
CLINICAL CANCER RESEARCH (2009)
High-resolution mapping of copy-number alterations with massively parallel sequencing
Derek Y. Chiang et al.
NATURE METHODS (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
A. Hochhaus et al.
LEUKEMIA (2008)
Mathematical Analysis of Copy Number Variation in a DNA Sample Using Digital PCR on a Nanofluidic Device
Simant Dube et al.
PLOS ONE (2008)
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel et al.
NATURE REVIEWS CANCER (2008)
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Junia V. Melo et al.
NATURE REVIEWS CANCER (2007)
Guidance for fluorescence in situ hybridization testing in hematologic disorders
Daynna J. Wolff et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
N Yanaihara et al.
CANCER CELL (2006)
Deletions of the 3′ BCR and 5′ ABL regions in patients with Philadelphia-positive chronic myeloid leukemia:: a one-step process occurring in about 10% of the cases without any evidence of genetic instability in the target cells
M Fournier et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
R Ren
NATURE REVIEWS CANCER (2005)
Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations
S Roumiantsev et al.
CANCER CELL (2004)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
CHM Jamieson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Biology of chronic myelogenous leukemia-signaling pathways of initiation and transformation
JV Melo et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2004)
Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over- representation
SM Gribble et al.
GENES CHROMOSOMES & CANCER (2003)
Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies
B Clarkson et al.
LEUKEMIA (2003)
Clinical applications of BCR-ABL molecular testing in acute leukemia
AL Nashed et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2003)
Deletion of the 5′ abl region in Philadelphia chromosome-positive chronic myeloid leukemia
F Morel et al.
LEUKEMIA (2003)
Human cytogenetics: 46 chromosomes, 46 years and counting
BJ Trask
NATURE REVIEWS GENETICS (2002)
Derivative chromosome 9 deletions in chronic myeloid leukemia:: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability
BJP Huntly et al.
BLOOD (2002)
The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA
EJ Baxter et al.
HUMAN MOLECULAR GENETICS (2002)
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins
A Demiroglu et al.
BLOOD (2001)
Deletion of BCR region 3′ in chronic myelogenous leukemia
FA González et al.
CANCER GENETICS AND CYTOGENETICS (2001)
Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia
BJP Huntly et al.
BLOOD (2001)
Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene:: expression profiling, resistance to interferon therapy, and poor prognosis
N Cohen et al.
CANCER GENETICS AND CYTOGENETICS (2001)
A step-by-step guide to non-linear regression analysis of experimental data using a Microsoft Excel spreadsheet
AM Brown
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2001)
Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals
B Mohr et al.
CANCER GENETICS AND CYTOGENETICS (2001)
Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis
E Kolomietz et al.
BLOOD (2001)
Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization
S Naumann et al.
LEUKEMIA RESEARCH (2001)
Deletion of the 5′-ABL region:: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients
C Herens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Lack of BCR/ABL reciprocal fusion in variant Philadelphia chromosome translocations:: a use of double fusion signal FISH and spectral karyotyping
VD Markovic et al.
LEUKEMIA (2000)
Cytogenetics of the chronic myeloid leukemia-derived cell line K562: Karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization
SM Gribble et al.
CANCER GENETICS AND CYTOGENETICS (2000)
Share Paper
